BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gimpel AL, Katsikis G, Sha S, Maloney AJ, Hong MS, Nguyen TNT, Wolfrum J, Springs SL, Sinskey AJ, Manalis SR, Barone PW, Braatz RD. Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies. Mol Ther Methods Clin Dev 2021;20:740-54. [PMID: 33738328 DOI: 10.1016/j.omtm.2021.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Green EA, Lee KH. Analytical methods to characterize recombinant adeno-associated virus vectors and the benefit of standardization and reference materials. Curr Opin Biotechnol 2021;71:65-76. [PMID: 34273809 DOI: 10.1016/j.copbio.2021.06.025] [Reference Citation Analysis]
2 Tustian AD, Bak H. Assessment of quality attributes for adeno-associated viral vectors. Biotechnol Bioeng 2021. [PMID: 34309017 DOI: 10.1002/bit.27905] [Reference Citation Analysis]
3 Hutanu A, Boelsterli D, Schmidli C, Montealegre C, Dang Thai MHN, Bobaly B, Koch M, Schwarz MA. Stronger together: Analytical techniques for recombinant adeno associated virus. Electrophoresis 2021. [PMID: 34821392 DOI: 10.1002/elps.202100302] [Reference Citation Analysis]
4 Khatwani SL, Pavlova A, Pirot Z. Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes. Mol Ther Methods Clin Dev 2021;21:548-58. [PMID: 33997103 DOI: 10.1016/j.omtm.2021.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sha S, Maloney AJ, Katsikis G, Nguyen TNT, Neufeld C, Wolfrum J, Barone PW, Springs SL, Manalis SR, Sinskey AJ, Braatz RD. Cellular pathways of recombinant adeno-associated virus production for gene therapy. Biotechnol Adv 2021;49:107764. [PMID: 33957276 DOI: 10.1016/j.biotechadv.2021.107764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hitchcock T. Manufacturing of AAV vectors: translational challenges from development to industrialisation. Emerg Top Life Sci 2021;5:725-8. [PMID: 34755857 DOI: 10.1042/ETLS20210179] [Reference Citation Analysis]
7 Roesch A, Zölls S, Stadler D, Helbig C, Wuchner K, Kersten G, Hawe A, Jiskoot W, Menzen T. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. J Pharm Sci 2021:S0022-3549(21)00689-4. [PMID: 34919969 DOI: 10.1016/j.xphs.2021.12.011] [Reference Citation Analysis]
8 Escandell JM, Pais DA, Carvalho SB, Vincent K, Gomes-Alves P, Alves PM. Leveraging rAAV bioprocess understanding and next generation bioanalytics development. Curr Opin Biotechnol 2022;74:271-7. [PMID: 35007989 DOI: 10.1016/j.copbio.2021.12.009] [Reference Citation Analysis]
9 Bee JS, O'Berry K, Zhang YZ, Phillippi MK, Kaushal A, DePaz RA, Marshall T. Quantitation of Trace Levels of DNA Released from Disrupted Adeno-Associated Virus Gene Therapy Vectors. J Pharm Sci 2021;110:3183-7. [PMID: 34107283 DOI: 10.1016/j.xphs.2021.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee NCO, Petrov NS, Larionov V, Kouprina N. Assembly of Multiple Full-Size Genes or Genomic DNA Fragments on Human Artificial Chromosomes Using the Iterative Integration System. Curr Protoc 2021;1:e316. [PMID: 34919348 DOI: 10.1002/cpz1.316] [Reference Citation Analysis]